Stay updated with breaking news from Barryj Simon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Viracta Therapeutics, Inc. (Nasdaq: VIRX) (Viracta or the Company), a precision oncology company targeting virus-associated malignancies, today...
Viracta Therapeutics Strengthens Company Leadership with New Appointments to the Board of Directors and Management Team Stephen Rubino, Ph.D., MBA and Barry J. Simon, M.D. appointed to the Board of Directors Cheryl A. Madsen, RAC appointed as Senior Vice President, Regulatory Affairs News provided by Share this article Share this article SAN DIEGO, March 4, 2021 /PRNewswire/ -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, today announced that it has strengthened its leadership team with the appointments of Drs. Stephen Rubi...